ACLY Antikörper (AA 306-502)
-
- Target Alle ACLY Antikörper anzeigen
- ACLY (ATP Citrate Lyase (ACLY))
-
Bindungsspezifität
- AA 306-502
-
Reaktivität
- Human, Maus, Ratte, Affe
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser ACLY Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunocytochemistry (ICC)
- Aufreinigung
- purified
- Immunogen
- Purified recombinant fragment of human ACLY (AA: 306-502 ) expressed in E. coli.
- Klon
- 5F8D11
- Isotyp
- IgG1
-
-
- Applikationshinweise
- ELISA: 1:10000, WB: 1:500 - 1:2000, IHC: 1:200 - 1:1000, ICC: 1:50, FCM: 1:200 - 1:400
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Purified antibody in PBS with 0.05 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- 4°C, -20°C for long term storage
-
-
ATP-citrate lyase reduction mediates palmitate-induced apoptosis in pancreatic beta cells." in: The Journal of biological chemistry, Vol. 285, Issue 42, pp. 32606-15, (2010) (PubMed).
: "Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomas." in: International journal of cancer. Journal international du cancer, Vol. 126, Issue 10, pp. 2282-95, (2010) (PubMed).
: "
-
ATP-citrate lyase reduction mediates palmitate-induced apoptosis in pancreatic beta cells." in: The Journal of biological chemistry, Vol. 285, Issue 42, pp. 32606-15, (2010) (PubMed).
-
- Target
- ACLY (ATP Citrate Lyase (ACLY))
- Andere Bezeichnung
- ACLY (ACLY Produkte)
- Synonyme
- ACLY antikoerper, DDBDRAFT_0205389 antikoerper, DDBDRAFT_0235360 antikoerper, DDB_0205389 antikoerper, DDB_0235360 antikoerper, ACL antikoerper, BcDNA:LD21334 antikoerper, CG8322 antikoerper, DmATPCL antikoerper, Dmel\\CG8322 antikoerper, anon-WO0140519.179 antikoerper, dATPCL antikoerper, l(2)01466 antikoerper, l(2)k09217 antikoerper, n(2)k09217 antikoerper, ATPCL antikoerper, CLATP antikoerper, A730098H14Rik antikoerper, AW538652 antikoerper, Clatp antikoerper, acly antikoerper, cb722 antikoerper, zgc:92008 antikoerper, ATP citrate lyase antikoerper, ATP citrate lyase S homeolog antikoerper, ATP-citrate synthase antikoerper, citrate synthase, mitochondrial antikoerper, atp-citrate synthase antikoerper, ATP citrate lyase a antikoerper, ACLY antikoerper, acly.S antikoerper, LOC587157 antikoerper, acly antikoerper, ATPCL antikoerper, LOC5564509 antikoerper, CpipJ_CPIJ010291 antikoerper, Bm1_26245 antikoerper, ACL antikoerper, Acly antikoerper, aclya antikoerper
- Hintergrund
-
Description: ATP citrate lyase is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA in many tissues. The enzyme is a tetramer (relative molecular weight approximately 440,000) of apparently identical subunits. It catalyzes the formation of acetyl-CoA and oxaloacetate from citrate and CoA with a concomitant hydrolysis of ATP to ADP and phosphate. The product, acetyl-CoA, serves several important biosynthetic pathways, including lipogenesis and cholesterogenesis. In nervous tissue, ATP citrate-lyase may be involved in the biosynthesis of acetylcholine. Two transcript variants encoding distinct isoforms have been identified for this gene. , , ,
Aliases: ACL, ATPCL, CLATP
- Molekulargewicht
- 125 kDa
- Gen-ID
- 47
- HGNC
- 47
- Pathways
- Warburg Effekt
-